Anticoagulation Policy After Venous Resection with a Pancreatectomy: a Systematic Review

Overview

Journal HPB (Oxford)

Publisher Elsevier

Specialty Gastroenterology

Date 2013 Dec 19

PMID 24344986

Citations 19

Authors

Manju D Chandrasegaram

Guy D Eslick

Wayne Lee

Mark E Brooke-Smith

Rob Padbury

Christopher S Worthley

John W Chen

John A Windsor

Affiliations

Soon will be listed here.

Abstract

Background: Portal vein (PV) resection is used increasingly in pancreatic resections. There is no agreed policy regarding anticoagulation.

Methods: A systematic review was performed to compare studies with an anticoagulation policy (AC+) to no anticoagulation policy (AC-) after venous resection.

Results: There were eight AC+ studies (n = 266) and five AC- studies (n = 95). The AC+ studies included aspirin, clopidogrel, heparin or warfarin. Only 50% of patients in the AC+ group received anticoagulation. There were more prosthetic grafts in the AC+ group (30 versus 2, Fisher's exact P < 0.001). The overall morbidity and mortality was similar in both groups. Early PV thrombosis (EPVT) was similar in the AC+ group and the AC- group (7%, versus 3%, Fisher's exact P = 0.270) and was associated with a high mortality (8/20, 40%). When prosthetic grafts were excluded there was no difference in the incidence of EPVT between both groups (1% vs 2%, Fisher's exact test P = 0.621).

Conclusion: There is significant heterogeneity in the use of anticoagulation after PV resection. Overall morbidity, mortality and EPVT in both groups were similar. EPVT has a high associated mortality. While we have been unable to demonstrate a benefit for anticoagulation, the incidence of EPVT is low in the absence of prosthetic grafts.

Citing Articles

Ancoaulation after pancatic urgery with venou resection (TIGRESS): What should we do? Results from an international survey.

Russell T, Ciprani D, Aroori S Ann Hepatobiliary Pancreat Surg. 2023; 27(4):423-427.

PMID: 37845022 PMC: 10700947. DOI: 10.14701/ahbps.23-065.

Portomesenteric Reconstruction during Whipple Procedure Using Autologous Left Renal Vein Patch Graft in a Patient with a Gastric Cancer Recurrence.

Ljubicic L, Petrovic I, Crkvenac Gregorek A, Silovski H Case Rep Surg. 2023; 2023:2717041.

PMID: 37151817 PMC: 10159741. DOI: 10.1155/2023/2717041.

Laparoscopic pancreatectomies for borderline tumors with major venous resections.

Borys M, Wysocki M, Budzynski A Wideochir Inne Tech Maloinwazyjne. 2023; 17(4):680-687.

PMID: 36818513 PMC: 9909760. DOI: 10.5114/wiitm.2022.116705.

The short- and long-term outcomes of laparoscopic pancreaticoduodenectomy combining with different type of mesentericoportal vein resection and reconstruction for pancreatic head adenocarcinoma: a Chinese multicenter retrospective cohort study.

Ouyang G, Zhong X, Cai Z, Liu J, Zheng S, Hong D Surg Endosc. 2023; 37(6):4381-4395.

PMID: 36759356 DOI: 10.1007/s00464-023-09901-2.

Venous wedge and segment resection during pancreatoduodenectomy for pancreatic cancer: impact on short- and long-term outcomes in a nationwide cohort analysis.

Groen J, Michiels N, van Roessel S, Besselink M, Bosscha K, Busch O Br J Surg. 2021; 109(1):96-104.

PMID: 34791069 PMC: 10364765. DOI: 10.1093/bjs/znab345.

References

Carrere N, Sauvanet A, Goere D, Kianmanesh R, Vullierme M, Couvelard A . Pancreaticoduodenectomy with mesentericoportal vein resection for adenocarcinoma of the pancreatic head. World J Surg. 2006; 30(8):1526-35. DOI: 10.1007/s00268-005-0784-4. View

Leach S, Lee J, Charnsangavej C, Cleary K, Lowy A, Fenoglio C . Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head. Br J Surg. 1998; 85(5):611-7. DOI: 10.1046/j.1365-2168.1998.00641.x. View

McLin V, Rimensberger P, Belli D, Wildhaber B . Anticoagulation following pediatric liver transplantation reduces early thrombotic events. Pediatr Transplant. 2010; 15(1):117-8. DOI: 10.1111/j.1399-3046.2010.01426.x. View

Zhou Y, Zhang Z, Liu Y, Li B, Xu D . Pancreatectomy combined with superior mesenteric vein-portal vein resection for pancreatic cancer: a meta-analysis. World J Surg. 2012; 36(4):884-91. DOI: 10.1007/s00268-012-1461-z. View

Ouaissi M, Sielezneff I, Pirro N, Mardion R, Chaix J, Merad A . Therapeutic anticoagulant does not modify thromboses rate vein after venous reconstruction following pancreaticoduodenectomy. Gastroenterol Res Pract. 2008; 2008:896320. PMC: 2586661. DOI: 10.1155/2008/896320. View

Widen A, Rolando N, Manousou P, Rolles K, Davidson B, Sharma D . Anticoagulation after liver transplantation: a retrospective audit and case-control study. Blood Coagul Fibrinolysis. 2009; 20(8):615-8. DOI: 10.1097/MBC.0b013e32832c87c8. View

Callery M, Chang K, Fishman E, Talamonti M, Traverso L, Linehan D . Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol. 2009; 16(7):1727-33. DOI: 10.1245/s10434-009-0408-6. View

Chakravarty K, Hsu J, Liu K, Yeh C, Yeh T, Hwang T . Prognosis and feasibility of en-bloc vascular resection in stage II pancreatic adenocarcinoma. World J Gastroenterol. 2010; 16(8):997-1002. PMC: 2828606. DOI: 10.3748/wjg.v16.i8.997. View

Wang F, Arianayagam R, Gill A, Puttaswamy V, Neale M, Gananadha S . Grafts for mesenterico-portal vein resections can be avoided during pancreatoduodenectomy. J Am Coll Surg. 2012; 215(4):569-79. DOI: 10.1016/j.jamcollsurg.2012.05.034. View

10.

Sanjay P, Takaori K, Govil S, Shrikhande S, Windsor J . 'Artery-first' approaches to pancreatoduodenectomy. Br J Surg. 2012; 99(8):1027-35. DOI: 10.1002/bjs.8763. View

11.

Allema J, Reinders M, van Gulik T, van Leeuwen D, de Wit L, Verbeek P . Portal vein resection in patients undergoing pancreatoduodenectomy for carcinoma of the pancreatic head. Br J Surg. 1994; 81(11):1642-6. DOI: 10.1002/bjs.1800811126. View

12.

Howard T, Villanustre N, Moore S, DeWitt J, LeBlanc J, Maglinte D . Efficacy of venous reconstruction in patients with adenocarcinoma of the pancreatic head. J Gastrointest Surg. 2003; 7(8):1089-95. DOI: 10.1016/j.gassur.2003.07.010. View

13.

Zhang J, Qian H, Leng J, Cui M, Qiu H, Zhou G . Long mesentericoportal vein resection and end-to-end anastomosis without graft in pancreaticoduodenectomy. J Gastrointest Surg. 2008; 13(8):1524-8. DOI: 10.1007/s11605-008-0777-3. View

14.

Warshaw A, Gu Z, Wittenberg J, Waltman A . Preoperative staging and assessment of resectability of pancreatic cancer. Arch Surg. 1990; 125(2):230-3. DOI: 10.1001/archsurg.1990.01410140108018. View

15.

Kendrick M, Sclabas G . Major venous resection during total laparoscopic pancreaticoduodenectomy. HPB (Oxford). 2011; 13(7):454-8. PMC: 3133711. DOI: 10.1111/j.1477-2574.2011.00323.x. View

16.

Smoot R, Christein J, Farnell M . An innovative option for venous reconstruction after pancreaticoduodenectomy: the left renal vein. J Gastrointest Surg. 2007; 11(4):425-31. PMC: 1852389. DOI: 10.1007/s11605-007-0131-1. View

17.

Riediger H, Makowiec F, Fischer E, Adam U, Hopt U . Postoperative morbidity and long-term survival after pancreaticoduodenectomy with superior mesenterico-portal vein resection. J Gastrointest Surg. 2006; 10(8):1106-15. DOI: 10.1016/j.gassur.2006.04.002. View

18.

Smoot R, Christein J, Farnell M . Durability of portal venous reconstruction following resection during pancreaticoduodenectomy. J Gastrointest Surg. 2006; 10(10):1371-5. DOI: 10.1016/j.gassur.2006.09.001. View

19.

Ayala R, Martinez-Lopez J, Cedena T, Bustelos R, Jimenez C, Moreno E . Recipient and donor thrombophilia and the risk of portal venous thrombosis and hepatic artery thrombosis in liver recipients. BMC Gastroenterol. 2011; 11:130. PMC: 3287260. DOI: 10.1186/1471-230X-11-130. View

20.

Lai E . Vascular resection and reconstruction at pancreatico-duodenectomy: technical issues. Hepatobiliary Pancreat Dis Int. 2012; 11(3):234-42. DOI: 10.1016/s1499-3872(12)60154-4. View